메뉴 건너뛰기




Volumn 30, Issue 3, 2009, Pages 295-302

Effects of new peritoneal dialysis solutions, pyridoxamine and AT1 receptor blocker, on TGF-β1 and VEGF expression in rat peritoneal mesothelial cells

Author keywords

AT1 receptor blocker; Peritoneal dialysis solution; Peritoneal mesothelial cells; Pyridoxamine; Transforming growth factor 1; Vascular endothelial growth factor

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; DIANEAL; EXTRANEAL; GLUCOSE; MESSENGER RNA; N 10; OLMESARTAN; PHOSPHATE BUFFERED SALINE; PYRIDOXAMINE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; VASCULOTROPIN;

EID: 67449113449     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000225929     Document Type: Article
Times cited : (7)

References (37)
  • 1
    • 0030065940 scopus 로고    scopus 로고
    • Morphological changes in the peritoneal vasculature of patients on CAPD with ultrafiltration failure
    • Honda K, Nitta K, Horita S, et al: Morphological changes in the peritoneal vasculature of patients on CAPD with ultrafiltration failure. Nephron 1996; 72: 171-176.
    • (1996) Nephron , vol.72 , pp. 171-176
    • Honda, K.1    Nitta, K.2    Horita, S.3
  • 2
    • 0036158071 scopus 로고    scopus 로고
    • Morphological changes in the peritoneal membrane of patients with renal disease
    • Williams JD, Craig KJ, Topley N, et al: Morphological changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002; 13: 470-479.
    • (2002) J Am Soc Nephrol , vol.13 , pp. 470-479
    • Williams, J.D.1    Craig, K.J.2    Topley, N.3
  • 3
    • 0037378448 scopus 로고    scopus 로고
    • Glucose-mediated induction of TGF-beta 1 and MCP-1 in mesothelial cells in vitro is osmolality and polyol pathway dependent
    • Wong TY, Phillips AO, Witowski J, et al: Glucose-mediated induction of TGF-beta 1 and MCP-1 in mesothelial cells in vitro is osmolality and polyol pathway dependent. Kidney Int 2003; 63: 1404-1416.
    • (2003) Kidney Int , vol.63 , pp. 1404-1416
    • Wong, T.Y.1    Phillips, A.O.2    Witowski, J.3
  • 4
    • 48249109924 scopus 로고    scopus 로고
    • The role of the TGF/Smad pathway in peritoneal fibrosis induced by peritoneal dialysis solutions
    • Yao Q, Pawlaczyk K, Ayala ER, et al: The role of the TGF/Smad pathway in peritoneal fibrosis induced by peritoneal dialysis solutions. Nephron Exp Nephrol 2008; 109:e71-e78.
    • (2008) Nephron Exp Nephrol , vol.109
    • Yao, Q.1    Pawlaczyk, K.2    Ayala, E.R.3
  • 5
    • 33750134948 scopus 로고    scopus 로고
    • Myofibroblast transdifferentiation of mesothelial cells is mediated by RAGE and contributes to peritoneal fibrosis in uraemia
    • De Vriese AS, Tilton RG, Mortier S, et al: Myofibroblast transdifferentiation of mesothelial cells is mediated by RAGE and contributes to peritoneal fibrosis in uraemia. Nephrol Dial Transplant 2006; 21: 2549-2555.
    • (2006) Nephrol Dial Transplant , vol.21 , pp. 2549-2555
    • De Vriese, A.S.1    Tilton, R.G.2    Mortier, S.3
  • 6
    • 0346900671 scopus 로고    scopus 로고
    • Basic mechanisms and clinical implications of peritoneal fibrosis
    • Margetts PJ, Bonniaud P: Basic mechanisms and clinical implications of peritoneal fibrosis. Perit Dial Int 2003; 23: 530-541.
    • (2003) Perit Dial Int , vol.23 , pp. 530-541
    • Margetts, P.J.1    Bonniaud, P.2
  • 7
    • 34447249074 scopus 로고    scopus 로고
    • Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: Pathologic significance and potential therapeutic interventions
    • Aroeira LS, Aguilera A, Sánchez-Tomero JA, et al: Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions. J Am Soc Nephrol 2007; 18: 2004-2013.
    • (2007) J Am Soc Nephrol , vol.18 , pp. 2004-2013
    • Aroeira, L.S.1    Aguilera, A.2    Sánchez-Tomero, J.A.3
  • 9
    • 0033436375 scopus 로고    scopus 로고
    • Glucose degradation product methyglyoxal enhances the production of vascular endothelial growth factor in peritoneal cells: Role in the functional and morphological alternations of peritoneal membranes in peritoneal dialysis
    • Inagi R, Miyata T, Yamamoto T, et al: Glucose degradation product methyglyoxal enhances the production of vascular endothelial growth factor in peritoneal cells: role in the functional and morphological alternations of peritoneal membranes in peritoneal dialysis. FEBS Lett 1999; 463: 260-264.
    • (1999) FEBS Lett , vol.463 , pp. 260-264
    • Inagi, R.1    Miyata, T.2    Yamamoto, T.3
  • 10
    • 0036151713 scopus 로고    scopus 로고
    • Vascular endothelial growth factor production and regulation in human peritoneal mesothelial cells
    • Mandel-Weber S, Cohen CD, Haslinger B, et al: Vascular endothelial growth factor production and regulation in human peritoneal mesothelial cells. Kidney Int 2002; 61: 570-578.
    • (2002) Kidney Int , vol.61 , pp. 570-578
    • Mandel-Weber, S.1    Cohen, C.D.2    Haslinger, B.3
  • 11
    • 0036099846 scopus 로고    scopus 로고
    • Effects of peritoneal dialysis solutions on the secretion of growth factors and extracellular matrix proteins by human peritoneal mesothelial cells
    • Ha H, Cha MK, Choi HN, et al: Effects of peritoneal dialysis solutions on the secretion of growth factors and extracellular matrix proteins by human peritoneal mesothelial cells. Perit Dial Int 2002; 22: 171-177.
    • (2002) Perit Dial Int , vol.22 , pp. 171-177
    • Ha, H.1    Cha, M.K.2    Choi, H.N.3
  • 12
    • 27144502651 scopus 로고    scopus 로고
    • Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: Role of vascular endothelial growth factor
    • Aroeira LS, Aguilera A, Selgas R, et al: Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor. Am J kidney Dis 2005; 46: 938-948.
    • (2005) Am J Kidney Dis , vol.46 , pp. 938-948
    • Aroeira, L.S.1    Aguilera, A.2    Selgas, R.3
  • 13
    • 26844483949 scopus 로고    scopus 로고
    • TGF- 1 induced by high glucose is controlled by angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker on cultured human peritoneal mesothelial cells
    • Kyuden Y, Ito T, Masaki T, et al: TGF- 1 induced by high glucose is controlled by angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker on cultured human peritoneal mesothelial cells. Perit Dial Int 2005; 25: 483-491.
    • (2005) Perit Dial Int , vol.25 , pp. 483-491
    • Kyuden, Y.1    Ito, T.2    Masaki, T.3
  • 14
    • 15044366331 scopus 로고    scopus 로고
    • Angiotensin II mediates high glucose-induced TGF- 1 and fibronectin upregulation in HPMC through reactive oxygen species
    • Noh H, Ha H, Yu MR, et al: Angiotensin II mediates high glucose-induced TGF- 1 and fibronectin upregulation in HPMC through reactive oxygen species. Perit Dial Int 2005;25: 38-47.
    • (2005) Perit Dial Int , vol.25 , pp. 38-47
    • Noh, H.1    Ha, H.2    Yu, M.R.3
  • 15
    • 0036786046 scopus 로고    scopus 로고
    • Angiotensin II receptor antagonists and angiotensin-converting enzyme inhibitors lower in vitro the formation of advanced glycation end products: Biochemical mechanisms
    • Miyata T, van Ypersele de Strihou C, Ueda Y, et al: Angiotensin II receptor antagonists and angiotensin-converting enzyme inhibitors lower in vitro the formation of advanced glycation end products: biochemical mechanisms. J Am Soc Nephrol 2002; 13: 2478-2487.
    • (2002) J Am Soc Nephrol , vol.13 , pp. 2478-2487
    • Miyata, T.1    Van Ypersele De Strihou, C.2    Ueda, Y.3
  • 16
    • 0029870323 scopus 로고    scopus 로고
    • Thiamine pyrophosphate and pyridoxamine inhibit the formation of antigenic advanced glycation end-products: Comparison with aminoguanidine
    • Booth AA, Khalifah RG, Hudson BG: Thiamine pyrophosphate and pyridoxamine inhibit the formation of antigenic advanced glycation end-products: comparison with aminoguanidine. Biochem Biophys Res Commun 1996; 220: 113-119.
    • (1996) Biochem Biophys Res Commun , vol.220 , pp. 113-119
    • Booth, A.A.1    Khalifah, R.G.2    Hudson, B.G.3
  • 17
    • 0024829013 scopus 로고
    • Isolation and propagation in vitro of peritoneal mesothelial cells
    • Hjelle JT, Golinska BT, Waters DC, et al: Isolation and propagation in vitro of peritoneal mesothelial cells. Perit Dial Int 1989; 9: 341-347.
    • (1989) Perit Dial Int , vol.9 , pp. 341-347
    • Hjelle, J.T.1    Golinska, B.T.2    Waters, D.C.3
  • 18
    • 0025605754 scopus 로고
    • Identification of endothelial and mesothelial cells in human omental tissue and in omentum-derived cultured cells by specific cell markers
    • Pötzsch B, Grulich-Henn J, Rössing R, et al: Identification of endothelial and mesothelial cells in human omental tissue and in omentum-derived cultured cells by specific cell markers. Lab Invest 1990; 63: 841-852.
    • (1990) Lab Invest , vol.63 , pp. 841-852
    • Pötzsch, B.1    Grulich-Henn, J.2    Rössing, R.3
  • 19
    • 0035126233 scopus 로고    scopus 로고
    • Effects of conventional and new peritoneal dialysis solutions on human peritoneal mesothelial cell viability and proliferation
    • Ha H, Yu MR, Choi HN, et al: Effects of conventional and new peritoneal dialysis solutions on human peritoneal mesothelial cell viability and proliferation. Perit Dial Int 2000; 20:S10-S18.
    • (2000) Perit Dial Int , vol.20
    • Ha, H.1    Yu, M.R.2    Choi, H.N.3
  • 20
    • 0027179156 scopus 로고
    • Heat sterilization of fluids for peritoneal dialysis gives rise to aldehydes
    • Nilsson-Thorell CB, Muscalu N, Andrén AH, et al: Heat sterilization of fluids for peritoneal dialysis gives rise to aldehydes. Perit Dial Int 1993; 13: 208-213.
    • (1993) Perit Dial Int , vol.13 , pp. 208-213
    • Nilsson-Thorell, C.B.1    Muscalu, N.2    Andrén, A.H.3
  • 21
    • 0025315939 scopus 로고
    • Isolation, culture and characterization of human peritoneal mesothelial cells
    • Stylianou E, Jenner LA, Davies M, et al: Isolation, culture and characterization of human peritoneal mesothelial cells. Kidney Int 1990; 37: 1563-1570.
    • (1990) Kidney Int , vol.37 , pp. 1563-1570
    • Stylianou, E.1    Jenner, L.A.2    Davies, M.3
  • 23
    • 0037560304 scopus 로고    scopus 로고
    • Preventive effect of cerivastatin on diabetic nephropathy through suppression of glomerular macrophage recruitment in a rat model
    • Ota T, Takamura T, Ando H, et al: Preventive effect of cerivastatin on diabetic nephropathy through suppression of glomerular macrophage recruitment in a rat model. Diabetologia 2003; 46: 843-851.
    • (2003) Diabetologia , vol.46 , pp. 843-851
    • Ota, T.1    Takamura, T.2    Ando, H.3
  • 24
    • 0029884212 scopus 로고    scopus 로고
    • More on the means comparison with unequal variances problem
    • Ames MH: More on the means comparison with unequal variances problem. J Biopharm Stat 1996; 6: 177-183.
    • (1996) J Biopharm Stat , vol.6 , pp. 177-183
    • Ames, M.H.1
  • 25
    • 0002392021 scopus 로고    scopus 로고
    • Reduced viability of human peritoneal mesothelial cells (HPMC) following 'chronic' exposure to differently sterilized peritoneal dialysis fluids (PDF) (Abstract)
    • Bender TO, Witowski J, Korybalska K, et al: Reduced viability of human peritoneal mesothelial cells (HPMC) following 'chronic' exposure to differently sterilized peritoneal dialysis fluids (PDF) (Abstract). Perit Dial Int 2000; 20(suppl 1):S9.
    • (2000) Perit Dial Int , vol.20 , Issue.SUPPL. 1
    • Bender, T.O.1    Witowski, J.2    Korybalska, K.3
  • 26
    • 4344696765 scopus 로고    scopus 로고
    • Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane
    • DOI 10.1111/j.1523-1755.2004.00879.x
    • Mortier S, Faict D, Schalkwijk CG, et al: Long-term exposure to new peritoneal dialysis solutions: effects on the peritoneal membrane. Kidney Int 2004; 66: 1257-1265. (Pubitemid 39121036)
    • (2004) Kidney International , vol.66 , Issue.3 , pp. 1257-1265
    • Mortier, S.1    Faict, D.2    Schalkwijk, C.G.3    Lameire, N.H.4    De Vriese, A.S.5
  • 27
    • 35548983542 scopus 로고    scopus 로고
    • The new peritoneal dialysis solutions: Friends only, or foes in part?
    • ter Wee PM, van Ittersum FJ: The new peritoneal dialysis solutions: friends only, or foes in part? Nat Clin Pract Nephrol 2007; 3: 604-612.
    • (2007) Nat Clin Pract Nephrol , vol.3 , pp. 604-612
    • Ter Wee, P.M.1    Van Ittersum, F.J.2
  • 28
    • 3042720430 scopus 로고    scopus 로고
    • The Euro-balance trial: The effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane
    • Williams JD, Topley N, Craig KJ, et al: The Euro-balance trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane. Kidney Int 2004; 66:408-418.
    • (2004) Kidney Int , vol.66 , pp. 408-418
    • Williams, J.D.1    Topley, N.2    Craig, K.J.3
  • 29
    • 23744484197 scopus 로고    scopus 로고
    • Biocompatibility of a bicarbonate/lactatebuffered PD fluid tested with a doublechamber cell culture system
    • Fusshoeller A, Baehr J, Grabensee B, et al: Biocompatibility of a bicarbonate/lactatebuffered PD fluid tested with a doublechamber cell culture system. Perit Dial Int 2005; 25: 387-393.
    • (2005) Perit Dial Int , vol.25 , pp. 387-393
    • Fusshoeller, A.1    Baehr, J.2    Grabensee, B.3
  • 30
    • 0035071561 scopus 로고    scopus 로고
    • Bicarbonate/ lactate-based solution increases cancer antigen 125 and decreases hyaluronic acid levels
    • Jones S, Holmes CJ, Krediet RT, et al: Bicarbonate/ lactate-based solution increases cancer antigen 125 and decreases hyaluronic acid levels. Kidney Int 2001; 59: 1529-1538.
    • (2001) Kidney Int , vol.59 , pp. 1529-1538
    • Jones, S.1    Holmes, C.J.2    Krediet, R.T.3
  • 31
    • 0027180627 scopus 로고
    • Glycated albumin in serum and dialysate of patients on continuous ambulatory peritoneal dialysis
    • Lamb E, Cattell WR, Dawnay A: Glycated albumin in serum and dialysate of patients on continuous ambulatory peritoneal dialysis. Clin Sci 1993; 84: 619-626.
    • (1993) Clin Sci , vol.84 , pp. 619-626
    • Lamb, E.1    Cattell, W.R.2    Dawnay, A.3
  • 32
    • 26844540903 scopus 로고    scopus 로고
    • Glucose free dialysis solutions: Inductors of inflammation or preservers of peritoneal membrane?
    • Martikainen TA, Teppo AM, Grönhagen-Riska C, et al: Glucose free dialysis solutions: inductors of inflammation or preservers of peritoneal membrane? Perit Dial Int 2005; 25: 453-460.
    • (2005) Perit Dial Int , vol.25 , pp. 453-460
    • Martikainen, T.A.1    Teppo, A.M.2    Grönhagen-Riska, C.3
  • 33
    • 33745505947 scopus 로고    scopus 로고
    • Effect of icodextrin-based peritoneal dialysis solution on peritoneal membrane
    • Moriishi M, Kawanishi H, Watanabe H, et al: Effect of icodextrin-based peritoneal dialysis solution on peritoneal membrane. Adv Perit Dial 2005; 21: 21-24.
    • (2005) Adv Perit Dial , vol.21 , pp. 21-24
    • Moriishi, M.1    Kawanishi, H.2    Watanabe, H.3
  • 34
    • 32644484516 scopus 로고    scopus 로고
    • Pyridoxamine improves functional, structural, and biochemical alterations and peritoneal membranes in uremic peritoneal dialysis rats
    • Kakuta T, Tanaka R, Satoh Y, et al: Pyridoxamine improves functional, structural, and biochemical alterations and peritoneal membranes in uremic peritoneal dialysis rats. Kidney Int 2005; 68: 1326-1336.
    • (2005) Kidney Int , vol.68 , pp. 1326-1336
    • Kakuta, T.1    Tanaka, R.2    Satoh, Y.3
  • 35
    • 34249082740 scopus 로고    scopus 로고
    • ACE inhibitor and AT1-receptor blocker attenuate the production of VEGF in mesothelial cells
    • Sauter M, Cohen CD, Wörnle M, et al: ACE inhibitor and AT1-receptor blocker attenuate the production of VEGF in mesothelial cells. Perit Dial Int 2007; 27: 167-172.
    • (2007) Perit Dial Int , vol.27 , pp. 167-172
    • Sauter, M.1    Cohen, C.D.2    Wörnle, M.3
  • 36
    • 0036183727 scopus 로고    scopus 로고
    • Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat
    • Degenhardt TP, Alderson NL, Arrington DD, et al: Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat. Kidney Int 2002; 61: 939-950.
    • (2002) Kidney Int , vol.61 , pp. 939-950
    • Degenhardt, T.P.1    Alderson, N.L.2    Arrington, D.D.3
  • 37
    • 33747135979 scopus 로고    scopus 로고
    • Technological advances in peritoneal dialysis research. Peritoneal mesothelial cell culture and biology
    • Yung S, Li FK, Chan TM: Technological advances in peritoneal dialysis research. Peritoneal mesothelial cell culture and biology. Perit Dial Int 2006; 26: 162-173.
    • (2006) Perit Dial Int , vol.26 , pp. 162-173
    • Yung, S.1    Li, F.K.2    Chan, T.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.